Updated February 8 at 11:08am
Biotechnology
33 results total, viewing 1 - 10
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
The I-195 Redevelopment District Commission moved closer Monday to securing the sale of five acres of land for a biological sciences and mixed-use development. more
The University of Rhode Island has received five grants totaling $629,550 from The Champlin Foundations. more
Twenty-six Real Jobs RI grant recipients were announced Monday by Gov. Gina M. Raimondo and the congressional delegation. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
Biotechnology giant Amgen Inc. posted third- quarter earnings that topped analysts’ estimates, driven by higher drug sales, and raised its forecast for the year. more
1 | 2 | 3 | 4 Next »